Posaconazole Tablet, Delayed Release
Product Images NDC 0406-7711

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 0406-7711). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Posaconazole Delayed Release Tablets 1)

Chemical structure of posaconazole, illustrating its molecular arrangement and bonding pattern as presented in the product labeling for the oral delayed-release tablet formulation.*

FDA Label Image

Principal Display Panel (100 mg Label)

POSACONAZOLE 100 mg delayed-release oral tablets label from SpecGx LLC. The label displays the product name, dosage strength, formulation type, quantity of 60 tablets, and the NDC number 0406-7711-60. It includes storage instructions, a note that tablets contain 100 mg posaconazole, and a tablet image showing strength imprint. The label also contains barcode and serialization details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.